{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:04:09Z","timestamp":1771923849558,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T00:00:00Z","timestamp":1551139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Universidad Cat\u00f3lica San Antonio de Murcia","award":["PMAFI\/09\/14"],"award-info":[{"award-number":["PMAFI\/09\/14"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13023-019-1031-7","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T14:04:31Z","timestamp":1551189871000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["High penetrance of acute intermittent porphyria in a Spanish founder mutation population and CYP2D6 genotype as a susceptibility factor"],"prefix":"10.1186","volume":"14","author":[{"given":"Mar\u00eda","family":"Barreda-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Buend\u00eda-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Glover-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Carazo-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Juliana","family":"Ballesta-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanesa","family":"L\u00f3pez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"S\u00e1nchez-Soler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidya","family":"Rodriguez-Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Teresa","family":"Serrano-Ant\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remedios","family":"Gil-Ferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria del Carmen","family":"Mart\u00ednez-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Carbonell-Meseguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Encarna","family":"Guill\u00e9n-Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,26]]},"reference":[{"issue":"5","key":"1031_CR1","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s10545-012-9544-4","volume":"36","author":"G Elder","year":"2013","unstructured":"Elder G, Harper P, Badminton M, Sandberg S, Deybach JC. The incidence of inherited porphyrias in Europe. J Inherit Metab Dis. 2013;36(5):849\u201357.","journal-title":"J Inherit Metab Dis"},{"issue":"9718","key":"1031_CR2","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S0140-6736(09)61925-5","volume":"375","author":"H Puy","year":"2010","unstructured":"Puy H, Gouya L, Deybach JC. Porphyrias. Lancet. 2010;375(9718):924\u201337.","journal-title":"Lancet."},{"issue":"8","key":"1031_CR3","doi-asserted-by":"publisher","first-page":"831","DOI":"10.4045\/tidsskr.13.0649","volume":"134","author":"M Mykletun","year":"2014","unstructured":"Mykletun M, Aarsand AK, Stole E, Villanger JH, Tollanes MC, Baravelli C, et al. Porphyrias in Norway. Tidsskrift for den Norske lageforening : tidsskrift for praktisk medicin, ny rakke. 2014;134(8):831\u20136.","journal-title":"Tidsskrift for den Norske lageforening : tidsskrift for praktisk medicin, ny rakke"},{"issue":"1","key":"1031_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/01.md.0000152455.38510.af","volume":"84","author":"M und zu fraunberg von","year":"2005","unstructured":"von und zu fraunberg M, Pischik E, Udd L, Kauppinen R. Clinical and biochemical characteristics and genotype-phenotype correlation in 143 Finnish and Russian patients with acute intermittent porphyria. Medicine (Baltimore). 2005;84(1):35\u201347.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"1031_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1046\/j.1365-2796.1997.00189.x","volume":"242","author":"Y Nordmann","year":"1997","unstructured":"Nordmann Y, Puy H, Da Silva V, Simonin S, Robreau AM, Bonaiti C, et al. Acute intermittent porphyria: prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France. J Intern Med. 1997;242(3):213\u20137.","journal-title":"J Intern Med"},{"issue":"11","key":"1031_CR6","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/humu.23067","volume":"37","author":"B Chen","year":"2016","unstructured":"Chen B, Solis-Villa C, Hakenberg J, Qiao W, Srinivasan RR, Yasuda M, et al. Acute intermittent Porphyria: predicted pathogenicity of HMBS variants indicates extremely low penetrance of the autosomal dominant disease. Hum Mutat. 2016;37(11):1215\u201322.","journal-title":"Hum Mutat"},{"issue":"7","key":"1031_CR7","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1080\/003655100300054891","volume":"60","author":"C Andersson","year":"2000","unstructured":"Andersson C, Floderus Y, Wikberg A, Lithner F. The W198X and R173W mutations in the porphobilinogen deaminase gene in acute intermittent porphyria have higher clinical penetrance than R167W. A population-based study. Scand J Clin Lab Invest. 2000;60(7):643\u20138.","journal-title":"Scand J Clin Lab Invest"},{"issue":"2","key":"1031_CR8","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.anpedi.2015.09.002","volume":"84","author":"MJ S\u00e1nchez-Soler","year":"2016","unstructured":"S\u00e1nchez-Soler MJ, Barreda-S\u00e1nchez M, Ballesta-Mart\u00ednez MJ, Gl\u00f3ver G, Guill\u00e9n-Navarro E. Acute intermittent porphyria in a paediatric population in the region of Murcia: phenotype and prevalence. An Pediatr (Barc). 2016;84(2):114\u20135.","journal-title":"An Pediatr (Barc)"},{"issue":"5","key":"1031_CR9","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/j.1651-2227.2003.tb02507.x","volume":"92","author":"J Hultdin","year":"2003","unstructured":"Hultdin J, Schmauch A, Wikberg A, Dahlquist G, Andersson C. Acute intermittent porphyria in childhood: a population-based study. Acta Paediatr. 2003;92(5):562\u20138.","journal-title":"Acta Paediatr"},{"issue":"3","key":"1031_CR10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10545-005-8050-3","volume":"28","author":"MN Badminton","year":"2005","unstructured":"Badminton MN, Elder GH. Molecular mechanisms of dominant expression in porphyria. J Inherit Metab Dis. 2005;28(3):277\u201386.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"1031_CR11","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/S0006-291X(83)80201-0","volume":"115","author":"N Hayashi","year":"1983","unstructured":"Hayashi N, Watanabe N, Kikuchi G. Inhibition by hemin of in vitro translocation of chicken liver delta-aminolevulinate synthase into mitochondria. Biochem Biophys Res Commun. 1983;115(2):700\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1031_CR12","first-page":"405","volume":"7","author":"BK May","year":"1990","unstructured":"May BK, Bhasker CR, Bawden MJ, Cox TC. Molecular regulation of 5-aminolevulinate synthase Diseases related to heme biosynthesis. Mol Biol Med. 1990;7(5):405\u201321.","journal-title":"Mol Biol Med"},{"issue":"11","key":"1031_CR13","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1016\/S0021-9258(18)60700-8","volume":"263","author":"G Srivastava","year":"1988","unstructured":"Srivastava G, Borthwick IA, Maguire DJ, Elferink CJ, Bawden MJ, Mercer JF, et al. Regulation of 5-aminolevulinate synthase mRNA in different rat tissues. J Biol Chem. 1988;263(11):5202\u20139.","journal-title":"J Biol Chem"},{"issue":"1","key":"1031_CR14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/jclinpath-2012-201367","volume":"67","author":"JT Marsden","year":"2014","unstructured":"Marsden JT, Rees DC. Urinary excretion of porphyrins, porphobilinogen and delta-aminolaevulinic acid following an attack of acute intermittent porphyria. J Clin Pathol. 2014;67(1):60\u20135.","journal-title":"J Clin Pathol"},{"issue":"8","key":"1031_CR15","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.medcli.2014.06.012","volume":"145","author":"C Herrero","year":"2015","unstructured":"Herrero C, Badenas C, Aguilera P, To-Figueras J. Acute intermittent porphyria: long-term follow up of 35 patients. Med Clin (Barc). 2015;145(8):332\u20137.","journal-title":"Med Clin (Barc)"},{"key":"1031_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fphar.2014.00061","volume":"5","author":"D Chiabrando","year":"2014","unstructured":"Chiabrando D, Vinchi F, Fiorito V, Mercurio S, Tolosano E. Heme in pathophysiology: a matter of scavenging, metabolism and trafficking across cell membranes. Front Pharmacol. 2014;5:61.","journal-title":"Front Pharmacol"},{"issue":"16","key":"1031_CR17","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.2174\/1568026043387115","volume":"4","author":"M Dickins","year":"2004","unstructured":"Dickins M. Induction of cytochromes P450. Curr Top Med Chem. 2004;4(16):1745\u201366.","journal-title":"Curr Top Med Chem"},{"issue":"24","key":"1031_CR18","doi-asserted-by":"publisher","first-page":"9127","DOI":"10.1073\/pnas.0401845101","volume":"101","author":"M Podvinec","year":"2004","unstructured":"Podvinec M, Handschin C, Looser R, Meyer UA. Identification of the xenosensors regulating human 5-aminolevulinate synthase. Proc Natl Acad Sci U S A. 2004;101(24):9127\u201332.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1031_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","volume":"138","author":"UM Zanger","year":"2013","unstructured":"Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013;138(1):103\u201341.","journal-title":"Pharmacol Ther"},{"issue":"6","key":"1031_CR20","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1007\/s004390000415","volume":"107","author":"L Christiansen","year":"2000","unstructured":"Christiansen L, Bygum A, Jensen A, Thomsen K, Brandrup F, Horder M, et al. Association between CYP1A2 polymorphism and susceptibility to porphyria cutanea tarda. Hum Genet. 2000;107(6):612\u20134.","journal-title":"Hum Genet"},{"issue":"6","key":"1031_CR21","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/j.0906-6705.2003.00095.x","volume":"12","author":"K Gardlo","year":"2003","unstructured":"Gardlo K, Selimovic D, Bolsen K, Ruzicka T, Abel J, Fritsch C. Cytochrome P4501A1 polymorphisms in a Caucasian population with porphyria cutanea tarda. Exp Dermatol. 2003;12(6):843\u20138.","journal-title":"Exp Dermatol"},{"issue":"9\u201310","key":"1031_CR22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2119\/2005-00047.Lavandera","volume":"12","author":"JV Lavandera","year":"2006","unstructured":"Lavandera JV, Parera VE, Batlle A, Buzaleh AM. CYP2D6 polymorphisms in patients with porphyrias. Mol Med. 2006;12(9\u201310):259\u201363.","journal-title":"Mol Med"},{"key":"1031_CR23","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1046\/j.1529-8817.2003.00114.x","volume":"68","author":"E Guillen-Navarro","year":"2004","unstructured":"Guillen-Navarro E, Carbonell P, Glover G, Sanchez-Solis M, Fernandez-Barreiro A. Novel HMBS founder mutation and significant intronic polymorphism in Spanish patients with acute intermittent porphyria. Ann Hum Genet. 2004;68:509\u201314.","journal-title":"Ann Hum Genet"},{"issue":"6","key":"1031_CR24","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00216-008-2291-6","volume":"392","author":"UM Zanger","year":"2008","unstructured":"Zanger UM, Turpeinen M, Klein K, Schwab M. Functional pharmacogenetics\/genomics of human cytochromes P450 involved in drug biotransformation. Anal Bioanal Chem. 2008;392(6):1093\u2013108.","journal-title":"Anal Bioanal Chem"},{"issue":"8","key":"1031_CR25","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0009-9120(97)00114-8","volume":"30","author":"ST Greene-Davis","year":"1997","unstructured":"Greene-Davis ST, Neumann PE, Mann OE, Moss MA, Schreiber WE, Welch JP, et al. Detection of a R173W mutation in the porphobilinogen deaminase gene in the Nova Scotian \"foreign Protestant\" population with acute intermittent porphyria: a founder effect. Clin Biochem. 1997;30(8):607\u201312.","journal-title":"Clin Biochem"},{"issue":"4","key":"1031_CR26","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1034\/j.1399-0004.2002.620406.x","volume":"62","author":"Y Floderus","year":"2002","unstructured":"Floderus Y, Shoolingin-Jordan PM, Harper P. Acute intermittent porphyria in Sweden. Molecular, functional and clinical consequences of some new mutations found in the porphobilinogen deaminase gene. Clin Genet. 2002;62(4):288\u201397.","journal-title":"Clin Genet"},{"issue":"5","key":"1031_CR27","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/cbf.1258","volume":"24","author":"A Menoyo","year":"2006","unstructured":"Menoyo A, del Rio E, Baiget M. Characterization of variant alleles of cytochrome CYP2D6 in a Spanish population. Cell Biochem Funct. 2006;24(5):381\u20135.","journal-title":"Cell Biochem Funct"},{"issue":"3","key":"1031_CR28","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s11033-013-2971-y","volume":"41","author":"J Vicente","year":"2014","unstructured":"Vicente J, Gonzalez-Andrade F, Soriano A, Fanlo A, Martinez-Jarreta B, Sinues B. Genetic polymorphisms of CYP2C8, CYP2C9 and CYP2C19 in Ecuadorian mestizo and Spaniard populations: a comparative study. Mol Biol Rep. 2014;41(3):1267\u201372.","journal-title":"Mol Biol Rep"},{"issue":"6","key":"1031_CR29","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1097\/01.ftd.0000186914.32038.a0","volume":"27","author":"G Gervasini","year":"2005","unstructured":"Gervasini G, Vizcaino S, Gasiba C, Carrillo JA, Benitez J. Differences in CYP3A5*3 genotype distribution and combinations with other polymorphisms between Spaniards and other Caucasian populations. Ther Drug Monit. 2005;27(6):819\u201321.","journal-title":"Ther Drug Monit"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1031-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1031-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1031-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T17:06:04Z","timestamp":1663002364000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1031-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,26]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1031"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1031-7","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,26]]},"assertion":[{"value":"27 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Research Ethics Board of the Hospital Cl\u00ednico Universitario Virgen de la Arrixaca. Informed consent to participate was obtained from all patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"59"}}